Eli Lilly & Co and other companies v Genentech Inc

Patent – Practice. The defendant pharmaceutical company's application to set aside proceedings in a patent dispute was dismissed. The Patents Court held that, among other things, as presently constituted, the proceedings would not engage art 24(4) of the Brussels I Council Regulation (recast) 1215/2012.